Default object view. Click to create a custom template, Node ID: 104693, Object ID: 62699

First-line treatment with sunitinib for type 1 and type 2 locally advanced or metastatic papillary renal cell carcinoma: a phase II study (SUPAP) by...

First-line treatment with sunitinib for type 1 and type 2 locally advanced or metastatic papillary renal cell carcinoma: a phase II study (SUPAP) by the French Genitourinary Group (GETUG)

No relation

Yes

No relation

No

23/03/2015 4:24 pm

No